
The success of drugs like Ozempic and Wegovy in treating weight loss could be driving Americans to spend less money on food, a top Walmart executive has said.
“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” John Furner, president and CEO of Walmart’s U.S. operations, said in an interview with Bloomberg on Wednesday. “Just less units, slightly less calories.”